Home
Storia in 3 fonti
Bristol Myers deepens AI investment with Anthropic deal
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-day activities.
- ·
biopharmadive.com
Bristol Myers deepens AI investment with Anthropic deal
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many…
- ·
qz.com
Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees
The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs
- ·
fiercepharma.com
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,